2056
India’s Cipla Signs Contract
Economy, Business And Markets

India’s Cipla Signs Contract

Mumbai-based pharmaceutical company Cipla has announced that it has signed a new contract with its existing distributor to produce generic drugs in Iran. The Indian firm’s investment of $37 million in a new production plant would see the company hold a 75 percent stake in the proposed unit. Cipla has said it will also offer new drug manufacturing equipment in addition to its technical know-how. Recently the company announced it acquired a 60 percent stake in an unnamed Sri Lankan-based company for $14 million, which would market its products in that country. It also acquired 51 percent stake in a UAE-based pharmaceutical company which has manufacturing and distribution business in Yemen for $21 million.

 

Short URL : http://goo.gl/04r7pD

You can also read ...

Valiollah Seif
Governor of the Central Bank of Iran said on Wednesday anti-...
Nat’l Virtual Currency in the Offing
Months after the idea was first publicized, it seems that Iran...
5th Indian Wheat Cargo Arrives for Afghanistan in Chabahar
India’s fifth consignment of wheat to be sent to Afghanistan...
Lexus’ New Crossover to Break Cover  in March
Lexus will pull the covers off of the production version of...
Presale Crosses  96,000 Gold Coins
The presale of Bahar Azadi gold coins priced at 14 million...
Spanish Foreign Minister Alfonso Dastis met with President Hassan Rouhani on Feb, 21.
Foreign ministers of the Netherlands and Spain are in Tehran...
The government has required car importers to pay the higher tariffs announced in January.
The government has finally allowed the clearance of imported...
Bank Loans Top $100b in 10 Months
Banks and credit institutions doled out more than 4.62...

Trending

Googleplus